Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne
Status:
Withdrawn
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This study will investigate the pharmacokinetics, safety and tolerability of dapsone and
adapalene following topical administration of 2 formulations of dapsone/adapalene fixed
combination gel, dapsone 5% gel (ACZONE®), and adapalene 0.3% gel (Differin®) in subjects
with acne vulgaris.